Spruce Biosciences, Inc. (SPRB)
60.78
-2.52
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
60.60
-0.18
(-0.30%)
After-Hours: 20:00
Spruce Biosciences Price to Book Value : 1.998 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.998 |
| August 27, 2026 | 2.081 |
| August 26, 2026 | 2.021 |
| August 25, 2026 | 2.084 |
| August 24, 2026 | 1.928 |
| August 21, 2026 | 1.696 |
| August 20, 2026 | 1.709 |
| August 19, 2026 | 1.741 |
| August 18, 2026 | 1.737 |
| August 17, 2026 | 1.740 |
| August 14, 2026 | 1.731 |
| August 13, 2026 | 1.636 |
| August 12, 2026 | 1.548 |
| August 11, 2026 | 1.526 |
| August 10, 2026 | 1.519 |
| August 07, 2026 | 1.541 |
| August 06, 2026 | 1.526 |
| August 05, 2026 | 1.532 |
| August 04, 2026 | 1.521 |
| August 03, 2026 | 1.418 |
| July 31, 2026 | 1.408 |
| July 30, 2026 | 1.426 |
| July 29, 2026 | 1.363 |
| July 28, 2026 | 1.368 |
| July 27, 2026 | 1.380 |
| Date | Value |
|---|---|
| July 24, 2026 | 1.416 |
| July 23, 2026 | 1.479 |
| July 22, 2026 | 1.466 |
| July 21, 2026 | 1.502 |
| July 20, 2026 | 1.463 |
| July 17, 2026 | 1.432 |
| July 16, 2026 | 1.456 |
| July 15, 2026 | 1.494 |
| July 14, 2026 | 1.524 |
| July 13, 2026 | 1.591 |
| July 10, 2026 | 1.646 |
| July 09, 2026 | 1.701 |
| July 08, 2026 | 1.637 |
| July 07, 2026 | 1.669 |
| July 06, 2026 | 1.705 |
| July 02, 2026 | 1.726 |
| July 01, 2026 | 1.728 |
| June 30, 2026 | 1.775 |
| June 29, 2026 | 2.213 |
| June 26, 2026 | 2.183 |
| June 25, 2026 | 2.090 |
| June 24, 2026 | 2.054 |
| June 23, 2026 | 2.065 |
| June 22, 2026 | 2.166 |
| June 18, 2026 | 2.074 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biogen, Inc. | 1.712 |
| PTC Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
Price to Book Value Related Metrics
| Price | 60.78 |
| Earnings Yield | -67.25% |
| Market Cap | 167.32M |